PDI expecting cuts from AstraZeneca: Reuters

Sales and marketing services provider PDI expects significant reductions in the 800 sales reps it contracts with AstraZeneca, according to a Reuters report. The reductions came as part of discussions with AstraZeneca over the status of fees for service contract sales engagements. AstraZeneca said it would comment further once it has more information about the scope and timing of the changes, the report said.
You must be a registered member of MMM to post a comment.

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.